Sewell, B., Francis, N., Harris, S., Gillespie, D., Bates, J., White, P., . . . Fitzsimmons, D. (2024). Cost-effectiveness of C-reactive protein point of care testing for safely reducing antibiotic consumption for acute exacerbations of chronic obstructive pulmonary disease as part of the multicentre, parallel-arm, open, individually randomised, controlled PACE trial. BMJ Open, 14(11), p. e084144. doi:10.1136/bmjopen-2024-084144

Sewell, Berni, et al. "Cost-effectiveness of C-reactive Protein Point of Care Testing for Safely Reducing Antibiotic Consumption for Acute Exacerbations of Chronic Obstructive Pulmonary Disease As Part of the Multicentre, Parallel-arm, Open, Individually Randomised, Controlled PACE Trial." BMJ Open 14, no. 11 (2024): e084144.

Sewell, Berni, et al. "Cost-effectiveness of C-reactive Protein Point of Care Testing for Safely Reducing Antibiotic Consumption for Acute Exacerbations of Chronic Obstructive Pulmonary Disease As Part of the Multicentre, Parallel-arm, Open, Individually Randomised, Controlled PACE Trial." BMJ Open 14.11 (2024): e084144.